These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 16295807)

  • 41. Prevention and treatment of osteoporosis in postmenopausal women.
    French L; Smith M; Shimp L
    J Fam Pract; 2002 Oct; 51(10):875-82. PubMed ID: 12401161
    [No Abstract]   [Full Text] [Related]  

  • 42. [Treatment of osteoporosis with parathyroid hormone].
    Syversen U; Halse JI
    Tidsskr Nor Laegeforen; 2008 Jan; 128(1):39-41. PubMed ID: 18183056
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Guidelines for the diagnosis, prevention and treatment of osteoporosis. Italian Osteoporosis, Mineral Metabolism, and Skeletal Diseases Society].
    Società Italiana dell'Osteoporosi, del Metabolismo Minerale e delle Malattie dello Scheletro
    Minerva Endocrinol; 2013 Mar; 38(1 Suppl 1):1-30. PubMed ID: 23539106
    [No Abstract]   [Full Text] [Related]  

  • 44. The waning effect of postmenopausal estrogen therapy on osteoporosis.
    Ettinger B; Grady D
    N Engl J Med; 1993 Oct; 329(16):1192-3. PubMed ID: 8377785
    [No Abstract]   [Full Text] [Related]  

  • 45. Osteoporosis prevention and treatment.
    Burger HG
    Med J Aust; 2000 Aug; 173(3):167-8. PubMed ID: 10979391
    [No Abstract]   [Full Text] [Related]  

  • 46. Importance of alfacalcidol in clinical conditions characterized by high rate of bone loss.
    Reginster JY; Lecart MP; Richy F
    J Rheumatol Suppl; 2005 Sep; 76():21-5. PubMed ID: 16142847
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessing compliance, acceptance, and tolerability of teriparatide in patients with osteoporosis who fractured while on antiresorptive treatment or were intolerant to previous antiresorptive treatment: an 18-month, multicenter, open-label, prospective study.
    Adachi JD; Hanley DA; Lorraine JK; Yu M
    Clin Ther; 2007 Sep; 29(9):2055-67. PubMed ID: 18035204
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bisphosphonates in the treatment of osteoporosis. Principles and efficacy.
    Papapoulos SE
    Ann Med Interne (Paris); 2000 Oct; 151(6):504-10. PubMed ID: 11104931
    [No Abstract]   [Full Text] [Related]  

  • 49. [Grave deficiencies in the diagnosis and therapy of osteoporosis. Expensive fracture landing].
    Wepner U
    MMW Fortschr Med; 2002 Feb; 144(7):20-1. PubMed ID: 11887727
    [No Abstract]   [Full Text] [Related]  

  • 50. [Osteoporosis: diagnosis, current approaches to treatment, prophylaxis].
    Rubin MP; Chechurin RE; Zubova OM
    Ter Arkh; 2002; 74(1):32-7. PubMed ID: 11878055
    [No Abstract]   [Full Text] [Related]  

  • 51. Osteoporosis prevention and treatment: its relevance to breast cancer patients.
    Hodsman AB
    Can J Oncol; 1995 Dec; 5 Suppl 1():28-32. PubMed ID: 8853521
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Management of severe osteoporosis.
    Miller PD
    Expert Opin Pharmacother; 2016; 17(4):473-88. PubMed ID: 26605922
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Osteoporosis prevention and the orthopaedic surgeon: when fracture care is not enough.
    Tosi LL; Lane JM
    J Bone Joint Surg Am; 1998 Nov; 80(11):1567-9. PubMed ID: 9840623
    [No Abstract]   [Full Text] [Related]  

  • 54. Preventing osteoporosis naturally.
    Henderson NK; Prince RL
    Med J Aust; 2001 Sep; 175(5):239-40. PubMed ID: 11587251
    [No Abstract]   [Full Text] [Related]  

  • 55. Prevention and treatment of osteoporosis in women.
    Stevenson J;
    Post Reprod Health; 2023 Mar; 29(1):11-14. PubMed ID: 36357006
    [No Abstract]   [Full Text] [Related]  

  • 56. Recommendations for the registration of new chemical entities used in the prevention and treatment of osteoporosis.
    Reginster JY; Compston JE; Jones EA; Kaufman JM; Audran M; Bouvenot G; Frati L; Mazzuoli G; Gennari C; Lemmel EM
    Calcif Tissue Int; 1995 Oct; 57(4):247-50. PubMed ID: 8673859
    [No Abstract]   [Full Text] [Related]  

  • 57. Bone densitometry in the clinical practice.
    Passariello R; Albanese CV; Kvasnovà M
    Eur Radiol; 1997; 7 Suppl 2():S2-10. PubMed ID: 9126454
    [No Abstract]   [Full Text] [Related]  

  • 58. What constitutes evidence for drug efficacy in osteoporosis?
    Kanis JA
    Drugs Aging; 1993; 3(5):391-9. PubMed ID: 8241604
    [No Abstract]   [Full Text] [Related]  

  • 59. Osteoporosis and exercise.
    O'Brien M
    Br J Sports Med; 1996 Sep; 30(3):191. PubMed ID: 8889107
    [No Abstract]   [Full Text] [Related]  

  • 60. [Osteoporosis in 1993. An information update].
    Champoux N
    Can Fam Physician; 1994 Jan; 40():112-21. PubMed ID: 8312747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.